Henry Schein (NASDAQ:HSIC) Sets New 12-Month High at $74.18


Share on StockTwits

Henry Schein, Inc. (NASDAQ:HSIC) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $74.18 and last traded at $74.01, with a volume of 8807 shares traded. The stock had previously closed at $72.38.

HSIC has been the subject of several analyst reports. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $63.00 target price for the company in a report on Wednesday, November 4th. BidaskClub upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Wednesday, January 6th. Barrington Research upgraded shares of Henry Schein from a “market perform” rating to an “outperform” rating and set a $72.00 price target on the stock in a report on Tuesday, November 3rd. Robert W. Baird raised shares of Henry Schein from a “neutral” rating to an “outperform” rating and raised their price objective for the stock from $70.00 to $79.00 in a research note on Monday, January 4th. Finally, TheStreet upgraded shares of Henry Schein from a “c” rating to a “b” rating in a research report on Monday, November 2nd. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $63.50.

The company has a quick ratio of 0.92, a current ratio of 1.49 and a debt-to-equity ratio of 0.14. The company has a 50-day moving average price of $67.86 and a 200-day moving average price of $64.60. The company has a market capitalization of $10.55 billion, a price-to-earnings ratio of 18.20, a P/E/G ratio of 3.65 and a beta of 0.85.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, November 2nd. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.26. The firm had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.45 billion. Henry Schein had a return on equity of 11.60% and a net margin of 6.14%. The firm’s revenue for the quarter was up 13.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.90 EPS. Equities analysts expect that Henry Schein, Inc. will post 2.94 EPS for the current fiscal year.

Hedge funds have recently made changes to their positions in the company. Handelsbanken Fonder AB acquired a new stake in shares of Henry Schein during the second quarter worth $2,226,000. Bradley Foster & Sargent Inc. CT acquired a new position in Henry Schein during the third quarter valued at approximately $1,210,000. FMR LLC grew its stake in Henry Schein by 519.7% in the second quarter. FMR LLC now owns 332,521 shares of the company’s stock valued at $19,416,000 after purchasing an additional 278,860 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH increased its position in shares of Henry Schein by 41.4% during the 3rd quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 17,672 shares of the company’s stock worth $1,039,000 after purchasing an additional 5,177 shares during the last quarter. Finally, Sawtooth Solutions LLC raised its stake in shares of Henry Schein by 28.6% during the 3rd quarter. Sawtooth Solutions LLC now owns 6,109 shares of the company’s stock worth $359,000 after purchasing an additional 1,359 shares in the last quarter. Institutional investors own 94.46% of the company’s stock.

About Henry Schein (NASDAQ:HSIC)

Henry Schein, Inc, a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Story: Why is insider trading harmful?

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.